Back to search

Article

Comparative diagnostic performance of the new chromatographic Affimer<sup>®</sup>-based rapid antigen detection against SARS-CoV-2 and other standard antigen tests for COVID-19 in a clinical setting

2022-01-26

Abstract excerpt

The availability of accurate and rapid diagnostic tools for COVID-19 is essential for tackling the ongoing pandemic. In this context, researchers in the UK have started testing a new Lateral Flow Device (LFD) based on proprietary Biotinylated anti SARS-CoV-2 S1 Affimer® technology that binds to the SARS-CoV2-S1 protein in anterior nasal swab samples, generating an ultra-sensitive method for detection. This interna...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aa37476a-aed3-5d66-a91a-036226c0c0d8
DOI
10.1101/2022.01.18.22269401
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative diagnostic performance of the new chromatographic Affimer<sup>®</sup>-based rapid antigen detection against SARS-CoV-2 and other standard antigen tests for COVID-19 in a clinical settingDOI 10.1101/2022.01.18.22269401
Select a neighboring publication to make it the new centre.